These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 29470550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8.
    Huang J, Ji EH, Zhao X, Cui L, Misuno K, Guo M, Huang Z, Chen X, Hu S.
    J Exp Clin Cancer Res; 2019 Mar 29; 38(1):138. PubMed ID: 30922366
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of CD147 expression promotes chemosensitivity in HNSCC cells by deactivating MAPK/ERK signaling pathway.
    Ma C, Wang J, Fan L, Guo Y.
    Exp Mol Pathol; 2017 Feb 29; 102(1):59-64. PubMed ID: 28062212
    [Abstract] [Full Text] [Related]

  • 7. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L, Hui A, Ignatchenko V, Shi W, Su S, Xu W, Huang SH, O'Sullivan B, Waldron J, Irish JC, Perez-Ordonez B, Liu FF, Kislinger T.
    Mol Cell Proteomics; 2012 Nov 29; 11(11):1404-15. PubMed ID: 22918226
    [Abstract] [Full Text] [Related]

  • 8. Sprouty2 protein is downregulated in human squamous cell carcinoma of the head and neck and suppresses cell proliferation in vitro.
    Lin CL, Chiang WF, Tung CL, Hsieh JL, Hsiao JR, Huang WT, Feng LY, Chang CH, Liu SY, Tsao CJ, Feng YH.
    Mol Med Rep; 2015 Jan 29; 11(1):547-54. PubMed ID: 25333206
    [Abstract] [Full Text] [Related]

  • 9. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC, Chen Z, Dong G, Ondrey FG, Wolf JS, Brown K, Siebenlist U, Van Waes C.
    Cancer Res; 1999 Jul 15; 59(14):3468-74. PubMed ID: 10416612
    [Abstract] [Full Text] [Related]

  • 10. Expression of RIPK1 and FADD are associated with chemosensitivity and survival in head and heck squamous cell carcinoma via tanshinone IIA-mediated modulation of the RIPK1-FADD-Caspase 8 complex.
    Shen B, Han W, Tan X, Gu KJ, Naseem DF, Zheng G, Li G, Lou J, Chen C.
    Mol Carcinog; 2024 Jul 15; 63(7):1406-1416. PubMed ID: 38695620
    [Abstract] [Full Text] [Related]

  • 11. Regulation and binding of pregnane X receptor by nuclear receptor corepressor silencing mediator of retinoid and thyroid hormone receptors (SMRT).
    Johnson DR, Li CW, Chen LY, Ghosh JC, Chen JD.
    Mol Pharmacol; 2006 Jan 15; 69(1):99-108. PubMed ID: 16219912
    [Abstract] [Full Text] [Related]

  • 12. BMS-275183-induced gene expression patterns in head and neck carcinoma.
    Yoo GH, Tran VR, Lemonnier LA, Ezzat WH, Subramanian G, Piechocki MP, Ensley JF, Lonardo F, Kim H, Lin HS.
    Am J Otolaryngol; 2007 Jan 15; 28(5):309-15. PubMed ID: 17826531
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
    Huang Z, Li H, Huang Q, Chen D, Han J, Wang L, Pan C, Chen W, House MG, Nephew KP, Guo Z.
    Mol Carcinog; 2014 Oct 15; 53(10):777-86. PubMed ID: 23661500
    [Abstract] [Full Text] [Related]

  • 15. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
    Nakashima T, Yasumatsu R, Kuratomi Y, Masuda M, Kuwano T, Toh S, Umezaki T, Cataltepe S, Silverman GA, Komune S.
    Head Neck; 2006 Jan 15; 28(1):24-30. PubMed ID: 16155915
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of TRIM24 Stimulates Proliferation and Glucose Metabolism of Head and Neck Squamous Cell Carcinoma.
    Wang H, Xue W, Jiang X.
    Biomed Res Int; 2018 Jan 15; 2018():6142843. PubMed ID: 29862279
    [Abstract] [Full Text] [Related]

  • 17. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
    Dong Y, Wang Z, Xie GF, Li C, Zuo WW, Meng G, Xu CP, Li JJ.
    Mol Cancer; 2017 Mar 29; 16(1):71. PubMed ID: 28356150
    [Abstract] [Full Text] [Related]

  • 18. SET protein accumulates in HNSCC and contributes to cell survival: antioxidant defense, Akt phosphorylation and AVOs acidification.
    Leopoldino AM, Squarize CH, Garcia CB, Almeida LO, Pestana CR, Sobral LM, Uyemura SA, Tajara EH, Silvio Gutkind J, Curti C.
    Oral Oncol; 2012 Nov 29; 48(11):1106-13. PubMed ID: 22739068
    [Abstract] [Full Text] [Related]

  • 19. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C.
    Cancer Res; 2007 May 15; 67(10):4657-64. PubMed ID: 17510391
    [Abstract] [Full Text] [Related]

  • 20. Ninein-like protein is overexpressed in head and neck squamous cell carcinoma and contributes to cancer growth and resistance to apoptosis.
    Yu L, Song Y, Zhang Q, Zhan Q.
    Oncol Rep; 2009 Oct 15; 22(4):789-98. PubMed ID: 19724857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.